Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kremmidiotis, G.
9  Ergebnisse:
Personensuche X
?
1

P0125 A phase 1/2 trial of BNC105P with everolimus in metas..:

Pal, S. ; Azad, A. ; Bhatia, S....
European Journal of Cancer.  51 (2015)  - p. e26 , 2015
Link: https://doi.org/10.1016/..
 
?
2

P.4.a.005 Pharmacodynamic effects of single oral doses of t..:

Kremmidiotis, G. ; Doolin, E. ; Metzger, D....
European Neuropsychopharmacology.  21 (2011)  - p. S528 , 2011
Link: https://doi.org/10.1016/..
 
?
3

P.2.h.001 The phospholipase C inhibitor U73122 inhibits the..:

O'Connor, S. ; Wagner, S. ; Huyard, B...
European Neuropsychopharmacology.  21 (2011)  - p. S451-S452 , 2011
Link: https://doi.org/10.1016/..
 
?
4

P.1.d.021 Evaluation of the novel anxiolytic compound BNC21..:

O'Connor, S. ; Huyard, B. ; Kremmidiotis, G...
European Neuropsychopharmacology.  20 (2010)  - p. S285 , 2010
Link: https://doi.org/10.1016/..
 
?
5

P.4.a.010 Evaluation of the pharmacokinetics and clinical t..:

Kremmidiotis, G. ; O'Connor, S. ; Doolin, E..
European Neuropsychopharmacology.  20 (2010)  - p. S526 , 2010
Link: https://doi.org/10.1016/..
 
?
6

P.4.d.001 BNC210 is a novel, fast acting compound with pote..:

O'Connor, S. ; Andriambeloson, E. ; Huyard, B....
European Neuropsychopharmacology.  18 (2008)  - p. S495 , 2008
Link: https://doi.org/10.1016/..
 
?
7

The Batten disease gene product (CLN3p) is a Golgi integral..:

Kremmidiotis, G
Human Molecular Genetics.  8 (1999)  3 - p. 523-531 , 1999
Link: https://doi.org/10.1093/..
 
?
8

Heterogeneity of CD44 expression among human B‐cell subpopu..:

Kremmidiotis, G. ; Ridings, J. ; Hicks, M....
Tissue Antigens.  51 (1998)  3 - p. 232-241 , 1998
Link: https://doi.org/10.1111/..
 
?
9

Integration of Transcript and Genetic Maps of Chromosome 16..:

CALLEN, D.F. ; LANE, S.A. ; KOZMAN, H....
Genomics.  29 (1995)  2 - p. 503-511 , 1995
Link: https://doi.org/10.1006/..
 
1-9